FilingSEC EDGAR6-K
RedHill Biopharma Completes Strategic Portfolio Reset and Asset Acquisitions
· SEC accepted
Stagecompleted
Filing content
The company announced the completion of a strategic portfolio reset, including the divestment of its Talicia business and the acquisition of commercial rights to Rebyota and Clenpiq.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…